We observed intriguing variations, which were quite significant among patients grouped by age, race, HCC stage, and tumor grade (Additional file 1 : Fig.
← all excerpts
Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma.
1
—
—